Comparing three treatments for gallbladder stones with common bile duct stones
Official title: Comparative Study of ERCP, ERCP Plus Laparoscopic Cholecystectomy, and Conservative Management in Patients With Concomitant Choledocholithiasis and Cholecystolithiasis.
Run by Qilu Hospital of Shandong University · NCT07413068 · Data updated 2026-11-12
This study tests which of three approaches—endoscopic gallbladder-preserving stone removal, ERCP with laparoscopic gallbladder removal, or conservative care—works best for adults with gallbladder stones and stones in the common bile duct.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Qilu Hospital of Shandong University Academic / other |
| Locations | 1 site (Jinan, Shandong) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | May 18, 2026 |
| Trial ID | NCT07413068 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with imaging-confirmed gallbladder and common bile duct stones, gallbladder stones ≤1 cm and normal gallbladder anatomy, and no prior biliary surgery who can consent to their preferred treatment.
✕Probably not a fit
Patients with large or complicated stones, atrophic or porcelain gallbladder, suspected gallbladder cancer, biliary strictures, prior biliary reconstruction, or major medical contraindications to endoscopy or surgery are unlikely to benefit from enrollment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort enrolls adults with cholelithiasis and concomitant common bile duct stones and assigns them to endoscopic transpapillary gallbladder-preserving cholecystolithotomy, ERCP plus laparoscopic cholecystectomy, or conservative treatment based on patient preference. Clinical data and patient-reported outcomes are collected at baseline and during follow-up to measure clinical success and complications. The study compares short-term and long-term postoperative complication rates and overall effectiveness across the three approaches. Eligible patients generally have small gallbladder stones (≤1 cm), normal gallbladder morphology, and no prior biliary or cholecystectomy surgery.
Why it matters
Potential benefit: If successful, the study could identify a safer or more effective option that preserves the gallbladder or reduces complications for patients with both gallbladder and common bile duct stones.
How similar studies have gone: ERCP plus laparoscopic cholecystectomy is an established approach with good supporting evidence, whereas transpapillary gallbladder-preserving cholecystolithotomy is less well-studied and remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria 1. Patients over the age of 18 years; 2. Ultrasound, MRCP, or other imaging examination findings (CT/MRI) clearly indicate a diagnosis of cholelithiasis with concomitant choledocholithiasis; 3. Patients with no history of gastrointestinal reconstruction surgery or cholecystectomy or previous biliary tract surgery (include history of ERCP); 4. Patients with every gallbladder stone ≤1 cm in diameter or sludge-like stones; 5. The morphology and size of the gallbladder are essentially normal and the thickness of the gallbladder wall is ≤3 mm; 6. Voluntary provision of signed informed consent. Exclusion Criteria 1. Atrophic cholecystitis; porcelain gallbladder; suspect malignant tumor of the gallbladder; stenosis of the lower segment of the common bile duct; Mirrizzi syndrome; 2. Unable to undergo endoscopic interventions for various reasons; 3. Absolute surgical contraindications, including severe hepatic, renal, cardiac and pulmonary insufficiency, history of cerebral coma and allergy to anesthesia, etc; 4. Presence of ectopic duodenal papilla or congenital pancreaticobiliary malformation; 5. Patients with severe coagulopathy, defined as an International Normalized Ratio (INR) \> 1.5 or patients with significant thrombocytopenia (platelet count \< 50 × 10⁹/L); 6. Pregnant women;
Where it's running
-
Qilu Hospital of Shandong University
Jinan, Shandong, China Recruiting
Study contacts
- Principal investigator: Tao Yu, MD — Qilu Hospital of Shandong University
- Study coordinator: Zhen Li, MD
- Email: qilulizhen@sdu.edu.cn
- Phone: 18560086106
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pancreatic stent to prevent pancreatitis after transpapillary gallbladder-preserving stone removal for patients with gallbladder and common bile duct stones
This trial will test whether adding a preventive pancreatic stent to standard rectal indomethacin lowers the risk of pancreatitis after transpapillary gallbladder-preserving stone removal in adults with gallbladder stones and common bile duct stones.
-
Peripheral nerve decompression plus nerve stimulation for painful diabetic neuropathy
This study looks at whether combining nerve decompression with nerve stimulation can help reduce pain in people with painful diabetic neuropathy.
-
Compare 10 Hz rTMS vs. iTBS for teens with major depressive disorder
This study tests whether two brain-stimulation approaches work for teens ages 11–19 who have major depressive disorder, by randomly assigning them to receive either 10 Hz rTMS or iTBS over two weeks.
-
Dual-Carrier-Frequency Brain Stimulation for Chronic Low Back Pain
Researchers test a brain-stimulation method to see if it can ease chronic non-specific low back pain in adults by targeting the hippocampus, alongside standard rehab.
-
Brain network patterns in muscle pain patients measured by MEG
This study tests whether MEG brain activity and connectivity patterns differ in people with muscle pain compared to healthy controls.
-
Iris Blood Flow Measured by OCTA in Diabetic Eye Disease
This study uses a non-invasive eye scan to see if iris blood flow differs across people with Type 2 diabetes and varying eye complications, including those without eye disease and those with neovascular glaucoma.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.